South Korea Cell Therapy Raw Materials Market Size & Outlook
Related Markets
South Korea cell therapy raw materials market highlights
- The South Korea cell therapy raw materials market generated a revenue of USD 242.9 million in 2025 and is expected to reach USD 934.1 million by 2033.
- The South Korea market is expected to grow at a CAGR of 18.6% from 2026 to 2033.
- In terms of segment, cell culture supplements was the largest revenue generating products in 2025.
- Media is the most lucrative products segment registering the fastest growth during the forecast period.
Cell therapy raw materials market data book summary
| Market revenue in 2025 | USD 242.9 million |
| Market revenue in 2033 | USD 934.1 million |
| Growth rate | 18.6% (CAGR from 2026 to 2033) |
| Largest segment | Cell culture supplements |
| Fastest growing segment | Media |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Media, Sera, Cell Culture Supplements, Antibodies, Reagents & Buffers |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Danaher Corp, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Grifols SA Ordinary Shares - Class A, Charles River Laboratories International Inc, Actylis, ACROBiosystems, RoosterBio, PromoCell GmbH |
Other key industry trends
- In terms of revenue, South Korea accounted for 4.4% of the global cell therapy raw materials market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China cell therapy raw materials market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,515.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Therapy Raw Materials Market Scope
Cell Therapy Raw Materials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| RoosterBio | View profile | 1-10 | Frederick, Maryland, United States, North America | http://roosterbio.com |
| ACROBiosystems | View profile | 251-500 | Newark, Delaware, United States, North America | https://www.acrobiosystems.com/ |
| Actylis | View profile | 501-1000 | Port Washington, New York, United States, North America | https://actylis.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.promocell.com/ |
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Stemcell Holdings Inc Ordinary Shares | View profile | - | 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 | https://www.stemcell-holdings.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
South Korea cell therapy raw materials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell therapy raw materials market will help companies and investors design strategic landscapes.
Cell culture supplements was the largest segment with a revenue share of 28.61% in 2025. Horizon Databook has segmented the South Korea cell therapy raw materials market based on media, sera, cell culture supplements, antibodies, reagents & buffers covering the revenue growth of each sub-segment from 2021 to 2033.
The market is growing rapidly, driven by the country’s strong commitment to biotechnology and medical innovation. As the demand for cell-based therapies, including stem cell treatments, gene therapies, and cancer immunotherapies, rises, the need for specialized raw materials like culture media, growth factors, and bioreactors is increasing. South Korea’s advanced healthcare infrastructure and significant investments in research and development help fuel this demand, positioning the country as a leader in the field of regenerative medicine.
In November 2024, Eisai Co., Ltd. and Biogen Inc. have launched LEQEMBI, a treatment for early Alzheimer’s disease, in South Korea. The drug received approval from the Ministry of Food and Drug Safety (MFDS) in May 2024. Moreover, the government is providing strong support to the biotech industry, with policies aimed at encouraging the development and commercialization of cell therapies. The country’s well-established manufacturing capabilities and collaborations between domestic and international companies are enhancing the availability of high-quality raw materials.
As South Korean companies continue to make strides in cell therapy development, the market for these materials is expected to grow even further, contributing to the global expansion of the cell therapy industry. With its focus on innovation and improving healthcare solutions, South Korea is becoming an important hub for the production and supply of raw materials essential for cell therapy advancements.
Reasons to subscribe to South Korea cell therapy raw materials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea cell therapy raw materials market databook
-
Our clientele includes a mix of cell therapy raw materials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea cell therapy raw materials market , including forecasts for subscribers. This country databook contains high-level insights into South Korea cell therapy raw materials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea cell therapy raw materials market size, by products, 2021-2033 (US$M)
South Korea Cell Therapy Raw Materials Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
